52 results on '"Holland J"'
Search Results
2. Age effect on the survival of patients with glioblastoma and anaplastic astrocytoma
3. High-dose chemotherapy with granulocyte colony-stimulating factor in advanced and/or metastatic soft tissue sarcomas
4. Surveillance in stage I non-seminomatous germ cell tumors of the testis (NSGCTT). Experience at the Instituto Nacional de Cancerología of México
5. Bleomycin, Ifosfamide and Carboplatin in advanced uterine cervix carcinoma: preliminary results
6. A phase II study of weekly 48 hours infusion with high-dose Fluorouracil (FU) in colorectal cancer
7. Phase II trial of Fluorouracil, Leucovorin and Interferon-α
8. Intensive weekly chemotherapy for advanced gastric cancer using 5-Fluorouracil, Cisplatin, Epirubicin, 6S-Leucovorin and Granulocyte-colony stimulating factor
9. Preoperative chemotherapy in non-small cell lung cancer (NSCLC) — A pilot study
10. Clinical pharmacokinetics of Pure 1 Folinic Acid and Fluorouracil during a phase I–II trial of Fluorouracil biomodulation in head and neck cancer patients. Preliminary data
11. Intensified concomitant chemoradiotherapy for poor prognosis head and neck cancer
12. A Phase II trial of induction Cisplatin, 5-FU, Leucovorin, and Interferon α-2B (PFL-α) followed by concurrent Hydroxyurea, 5-FU and radiation for Stage IV squamous cell cancers of the head and neck (HNC)
13. Adjuvant chemohormonal therapy with Cyclophosphamide, Doxorubicin and 5-Fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) in node-positive breast cancer patients
14. Cyclophosphamide, Novantrone, Fluorouracil (CNF) + G-CSF Neo-Adjuvant chemotherapy in operable breast cancer
15. A Phase II study of 2-weekly high-dose Epirubicin with r-met-hu G-CSF in advanced breast cancer
16. An in vitro model for neutrophil-mediated damage to tumour vasculature: effects of a novel anti-cancer agent
17. Potentiation of 5-Fluorouracil-[6RS]leucovorin cytotoxicity by recombinant human Interferon-α2A in colon carcinoma cells
18. 5-FU + Folinic Acid (FA, Rescuvolin®) i.a., 5-FU + FA i.v., 5-FUDR i.a., or 5-FUDR i.a. + i.v. for treatment of non-resectable colorectal liver metastases ?
19. Chemo-immunotherapy of metastatic malignant melanoma The Salpetriere Hospital (SOMPS) experience
20. Current status of therapy for small cell carcinoma of the lung
21. Role of pathologic response after primary chemoradiotherapy and esophagectomy for predicted T3–4 N0-1 M0 squamous carcinoma of the thoracic esophagus
22. Preoperative 5-Fluorouracil in resectable colorectal cancer. Preliminary results of a prospective randomized trial
23. Double 5-FU modulation with folinic acid and recombinant alfa2b-Interferon : a phase I–II study in metastatic colorectal cancer patients
24. Application of dose intensity to Neo-Adjuvant therapy
25. 5-Fluorouracil modulation in head and neck cancer
26. Circadian chemotherapy against stage IIIB-IV non-small-cell lung cancer (NSCLC) with 5-Fluorouracil (5-FU), folinic acid (FOL) and cisplatin (CDDP) via a multichannel programmable pump. Preliminary results
27. The combination of Etoposide and Cyclophosphamide as Neo-Adjuvant chemotherapy for osteosarcoma
28. Interferon-α-2b + fotemustine in disseminated malignant melanoma
29. Treatment of osteosarcoma with Cisplatin and Doxorubicin either as Adjuvant or Neo-Adjuvant chemotherapy
30. The prediction of treatment outcomes in non-seminomatous extragonadal germ cell tumors (NSEGCT) by using different criteria of « poor » and « good » risk
31. Advanced seminoma treated with chemotherapy (CT)
32. Neo-Adjuvant chemotherapy for inoperable gastric cancer via local and general delivery routes (FLEP Therapy)
33. Mitomycin, Ifosfamide and Platin (MIP) in advanced and disseminated non-small cell lung cancer (NSCLC)
34. Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinoma
35. A combination chemotherapy with Ifosfamide (I), Cisplatin (P) and Etoposide (E) for advanced non-small cell lung cancer (NSCLC)
36. Concomitant radiotherapy and Cisplatin in head and neck cancer: a pilot study
37. Long-term follow-up of the patients with recurrent or advanced head and neck cancer who received chemotherapy for palliation
38. Hepatic arterial chemotherapy (HAI) for unresectable liver metastases from gastrointestinal cancer
39. Neo-Adjuvant therapy for esophagus cancer: a coming of age
40. High-dose chemotherapy with hematologic rescue for high-risk non-seminomatous germ cell tumors
41. Non surgical multimodality treatment of squamous cell cancer of the esophagus
42. Dose response relationship with epirubicin in Neo-Adjuvant combination chemotherapy for advanced breast cancer. End results of a prospective randomized trial
43. Current development of fotemustine: perspectives
44. Cisplatin, 5-Fluorouracil and high dose oral Leucovorin (PFL) with Methotrexate and Piritrexim as Neo-Adjuvant chemotherapy for head and neck cancer
45. The current status of therapy for aggressive non-Hodgkin lymphoma
46. Pharmacokinetic study of Neo-Adjuvant chemotherapy combining Carboplatin, Cisplatin and 5-Fluorouracil in head and neck squamous cell carcinoma
47. Neo-Adjuvant chemotherapy for invasive thymoma: an interim analysis
48. Neo-Adjuvant treatment in locally advanced thymoma
49. Neo-Adjuvant chemotherapy in locally advanced invasive thymomas
50. Control of refractory nausea and vomiting with adjuvant propofol during cancer chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.